No. 23-1231
Cellect, LLC v. Katherine K. Vidal, Under Secretary of Commerce for Intellectual Property and Director, United States Patent and Trademark Office
Amici (11)
Experienced Counsel
Tags: equitable-doctrine good-faith-procurement investment-backed-expectations judicial-doctrine obviousness-type-double-patenting patent patent-invalidation patent-term-adjustment statutory-interpretation statutory-provisions
Latest Conference:
2024-09-30
Question Presented (from Petition)
Whether a patent procured in good faith can be invalidated on the ground that statutory Patent Term Adjustment, which requires lengthening a patent's term to account for time lost to Patent and Trademark Office delays, can trigger a judge-made patent-invalidation doctrine.
Question Presented (AI Summary)
Whether a patent procured in good faith can be invalidated on the ground that statutory Patent Term Adjustment, which requires lengthening a patent's term to account for time lost to Patent and Trademark Office delays, can trigger a judge-made patent-invalidation doctrine
Docket Entries
2024-10-07
Petition DENIED.
2024-09-04
Reply of petitioner Cellect LLC filed. (Distributed)
2024-09-04
Reply of Cellect LLC submitted.
2024-09-04
DISTRIBUTED for Conference of 9/30/2024.
2024-08-21
Brief amicus curiae of Inari Agriculture, Inc. filed.
2024-08-21
Brief of respondent Katherine K. Vidal, Under Secretary of Commerce for Intellectual Property and Director, United States Patent and Trademark Office in opposition filed.
2024-08-21
Amicus brief of Inari Agriculture, Inc. submitted.
2024-08-21
Brief of respondent Vidal, Katherine K. in opposition filed.
2024-07-01
Motion to extend the time to file a response is granted and the time is further extended to and including August 21, 2024.
2024-06-28
Motion to extend the time to file a response from July 22, 2024 to August 21, 2024, submitted to The Clerk.
2024-06-28
Motion of Vidal, Katherine K. for an extension of time submitted.
2024-06-21
Brief amicus curiae of American Intellectual Property Law Association filed.
2024-06-21
Brief amici curiae of Sanofi, et al. filed.
2024-06-21
Brief amici curiae of Sonos, Inc., et al. filed.
2024-06-21
Brief amici curiae of Pharmaceutical Research and Manufacturers of America, et al. filed.
2024-06-21
Brief amici curiae of Sanofi, BeiGene, LTD., Merck Sharp & Dohme LLC, EMD Serono, Inc., and Pfizer Inc. filed.
2024-06-21
Brief amici curiae of Sonos, Inc., RingCentral, Inc., NAGRA Kudelski Group, and Capstan Therapeutics, Inc. filed.
2024-06-21
Brief amici curiae of Pharmaceutical Research and Manufacturers of America; et al. filed.
2024-06-21
Brief amicus curiae of Teige P. Sheehan filed.
2024-06-21
Amicus brief of Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization submitted.
2024-06-21
Amicus brief of Teige P. Sheehan submitted.
2024-06-21
Amicus brief of American Intellectual Property Law Association submitted.
2024-06-20
Brief amicus curiae of Intellectual Property Owners Association filed.
2024-06-20
Amicus brief of Intellectual Property Owners Association submitted.
2024-06-03
Motion to extend the time to file a response is granted and the time is extended to and including July 22, 2024.
2024-05-30
Motion to extend the time to file a response from June 21, 2024 to July 22, 2024, submitted to The Clerk.
2024-05-28
Brief amicus curiae of The New York Intellectual Property Law Association filed.
2024-05-20
Petition for a writ of certiorari filed. (Response due June 21, 2024)
2024-04-08
Application (23A883) granted by The Chief Justice extending the time to file until May 20, 2024.
2024-04-02
Application (23A883) to extend the time to file a petition for a writ of certiorari from April 18, 2024 to May 20, 2024, submitted to The Chief Justice.
Attorneys
American Intellectual Property Law Association
Sophie Feifei Wang — Choate Hall & Stewart LLP, Amicus
Cellect LLC
Roy T. Englert Jr. — Kramer Levin Naftalis & Frankel LLP, Petitioner
Inari Agriculture, Inc.
Intellectual Property Owners Association
Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization
Jeffrey P. Kushan — Sidley Austin LLP, Amicus
Sanofi, BeiGene, LTD., Merck Sharp & Dohme LLC, EMD Serono, Inc., and Pfizer Inc.
David Keith Barr — Venable LLP, Amicus
Sonos, Inc., RingCentral, Inc., NAGRA Kudelski Group, and Capstan Therapeutics, Inc.
Teige P. Sheehan
The New York Intellectual Property Law Association
Jeffrey I. D. Lewis — Foley Hoag LLP, Amicus
Vidal, Katherine K.
Elizabeth B. Prelogar — Respondent